Product Information
FENOFIBRIC ACID DR 45 MG CAP is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $0.1499 per EA under NDC 00115155410. Its NADAC has been published 442 times since Feb 14, 2018.
FDA first approved this application on Dec 15, 2008.
The High Outlier badge above means this manufacturer's average price in the Fenofibric Acid market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
45 mg/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
00115155410
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Effective Date
7/22/2026
Active Ingredients
FENOFIBRIC ACIDApproval Type
Authorized Generic (NDA)
FDA Application
NDA022224FDA Approved
12/15/2008
On Market Since
9/12/2016
Pharmacological Classes
Price Statistics
The NADAC for FENOFIBRIC ACID DR 45 MG CAP has been published 442 times since Feb 14, 2018, and over the history we have for it it has declined 81.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1499 per EA |
|---|---|
| All-time high | $0.8404 (Dec 11, 2019) |
| All-time low | $0.1018 (Nov 20, 2024) |
| 52-week high | $0.1583 |
| 52-week low | $0.1423 |
| Median price | $0.2277 |
| Average price | $0.3367 |
| Largest weekly change | +100.8% (Dec 22, 2021) |
| Weeks tracked | 442 |
| Tracking since | Feb 14, 2018 |
1W
N/A
1M
N/A
3M
-1.0%
6M
-1.8%
1Y
-4.8%
3Y
+7.7%
5Y
-32.4%
All
-81.1%
Last surveyed Jul 29, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals of New York LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Fenofibric Acid market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Peroxisome Proliferator Receptor alpha Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FENOFIBRIC ACID DR 45 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for FENOFIBRIC ACID DR 45 MG CAP, manufactured by Amneal Pharmaceuticals of New York LLC, is $0.1499 per EA (NDC 00115155410), effective Jul 29, 2026.
How has the price of FENOFIBRIC ACID DR 45 MG CAP changed over time?
Over the history we have for it, the NADAC for FENOFIBRIC ACID DR 45 MG CAP has declined 81.1%. It has been tracked across 442 weekly CMS publications since Feb 14, 2018.
What are the highest and lowest recorded NADAC prices for FENOFIBRIC ACID DR 45 MG CAP?
Since Feb 14, 2018, the NADAC for FENOFIBRIC ACID DR 45 MG CAP has ranged from a low of $0.1018 (Nov 20, 2024) to a high of $0.8404 (Dec 11, 2019), with a median of $0.2277 per EA.
Are there cheaper alternatives to FENOFIBRIC ACID DR 45 MG CAP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as FENOFIBRIC ACID DR 45 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures FENOFIBRIC ACID DR 45 MG CAP?
FENOFIBRIC ACID DR 45 MG CAP (NDC 00115155410) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.